Advertisement
Advertisement
U.S. Markets open in 2 hrs 15 mins
Advertisement
Advertisement
Advertisement
Advertisement

Bright Minds Biosciences Inc. (DRUG)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3000+0.0100 (+0.78%)
At close: 04:00PM EDT
1.2600 -0.04 (-3.08%)
Pre-Market: 07:06AM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced the appoin

  • GlobeNewswire

    Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

    In predictive animal models, BMB-101 demonstrated significant reduction in both the number and intensity of epileptic seizuresVANCOUVER, British Columbia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that it has dosed the first patient in a Phase I trial (NCT 05397

  • GlobeNewswire

    Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

    THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”) is pleased to announce that it has closed its previously announced overnight marketed offering (the “Offering”) of 2,858,000 units of the Company at a price of $1.40 per

Advertisement
Advertisement